DNA Microarray Market Size Forecast To Achieve $6.35 Billion By 2030 With 10.7% CAGR
The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.
How Does The Forecasted Market Size Of The DNA Microarray Market Compare Between 2026 And 2030?
The dna microarray market has seen rapid expansion in recent years. It is anticipated to increase from $3.78 billion in 2025 to $4.24 billion in 2026, exhibiting a compound annual growth rate (CAGR) of 12.1%. The growth observed historically is attributable to factors like the expansion of genomic research, initial gene expression studies, the requirements of pharmaceutical R&D, financial support for academic research, and the identification of disease biomarkers.
The dna microarray market is projected to witness substantial expansion in the coming years, with its size expected to ascend to $6.36 billion by 2030, demonstrating a compound annual growth rate (CAGR) of 10.7%. This anticipated growth throughout the forecast period stems from factors such as ongoing precision medicine research, the integration with AI analytics, the advancement of translational genomics, efforts in drug target identification, and progress in personalized healthcare research. Prominent trends anticipated in this period include the rising utilization of gene expression profiling, the broadening scope of microarray applications in research, increased adoption in the discovery of biomarkers, seamless integration with sophisticated data analysis tools, and a growing demand for high-throughput genomic screening.
Download A Free Sample Report For Comprehensive Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=16039&type=smp
Which Drivers Are Advancing The DNA Microarray Market Growth?
The DNA microarray market is expected to grow as personalized medicine sees rapid adoption. This approach involves tailoring medical treatment to individual patient characteristics, such as genetic, environmental, and lifestyle factors. Its increasing uptake is a result of advancements in ‘omics’ technologies, improved data-integration capabilities, and heightened awareness among healthcare professionals and patients, making patient-specific therapies more viable and accessible. The DNA microarray market supports this trend by enabling gene expression profiling and genomic analysis, which are essential for creating individualized treatment plans and precision diagnostics. As an illustration, in February 2024, the Personalized Medicine Coalition (PMC), a US-based non-profit organisation, reported that the U.S. Food and Drug Administration (FDA) approved 16 novel personalized therapies for rare diseases in 2023, an increase from 6 in 2022, indicating an accelerated embrace of precision medicine strategies. Therefore, the swift adoption of personalized medicine is a key driver for the expansion of the DNA microarray market.
What Segment Types Are Included In The DNA Microarray Market Analysis?
The dna microarray market covered in this report is segmented –
1) By Type: Complementary DNA Microarrays, Oligonucleotide DNA Microarrays, Other Types
2) By Application: Gene Expression Analysis, Genotyping, Other Applications
3) By End-user: Pharmaceutical And Biotechnology Companies, Diagnostic Centers, Hospitals And Clinics, Academic And Research Institute, Other End-Users
Subsegments:
1) By Complementary DNA Microarrays: Gene Expression Profiling, Comparative Genomic Hybridization (CGH), Quantitative Analysis
2) By Oligonucleotide DNA Microarrays: Gene Expression Microarrays, Single Nucleotide Polymorphism (SNP) Arrays, DNA Methylation Arrays, Pathogen Detection Arrays
3) By Other Types: Protein-DNA Microarrays, Tissue Microarrays, Affinity Microarrays, Spotted DNA Microarrays
Which Trends Are Contributing To Changes In The DNA Microarray Market?
Leading companies in the DNA microarray market are prioritizing the development of advanced technologies, such as rapid-turnaround microarray platforms, to enhance workflow efficiency, expedite data delivery, and strengthen their competitive edge. A rapid-turnaround microarray platform is defined as a high-resolution genomic analysis system engineered to deliver comprehensive results within a compressed timeframe, typically two days, thereby facilitating quicker research progress and more timely clinical decision-making. For example, in August 2023, Thermo Fisher Scientific Inc., a US-based biotechnology company, launched the Applied Biosystems CytoScan HD Accel array. This chromosomal microarray provides an industry-leading two-day turnaround time and extended whole-genome coverage across more than 5,000 key genomic regions, empowering cytogenetic laboratories to achieve greater productivity, improved efficiency, and more actionable insights for prenatal, postnatal, and oncology research.
Which Key Players Are Active In The DNA Microarray Market?
Major companies operating in the dna microarray market are Roche Holding AG, Thermo Fisher Scientific Inc., Danaher Corporation, Merck KGaA, Agilent Technologies Inc., PerkinElmer Inc., Illumina Inc., bioMérieux SA, Schott AG, Bio-Rad Laboratories Inc., QIAGEN N.V., Bioneer Corporation, CapitalBio Technology Co. Ltd., Eurofins Genomics LLC, Savyon Diagnostics Ltd., Oxford Gene Technology, Sengenics Corporation LLC, Affymetrix, BioCat GmbH, Scienion AG, LC Sciences, Arrayit Corporation, Akonni Biosystems Inc., Arraystar Inc., Febit Holding GmbH
Access The Complete DNA Microarray Market Report:
https://www.thebusinessresearchcompany.com/report/dna-microarray-global-market-report
Which Region Leads The DNA Microarray Market By Size?
North America was the largest region in the DNA microarray market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the dna microarray market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Access DNA Microarray Market Report for Deeper Competitive Insights
https://www.thebusinessresearchcompany.com/customise?id=16039&type=smp
Browse Through More Reports Similar to the Global DNA Microarray Market 2026, By The Business Research Company
Microarray Global Market Report 2026
https://www.thebusinessresearchcompany.com/report/microarray-global-market-report
Tissue Microarray Global Market Report 2026
https://www.thebusinessresearchcompany.com/report/tissue-microarray-global-market-report
Microarray Scanners Global Market Report 2026
https://www.thebusinessresearchcompany.com/report/microarray-scanners-global-market-report
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas: +1 310-496-7795
Asia: +44 7882 955267 & +91 8897263534
Europe: +44 7882 955267
Email us at: marketing@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
